GE Healthcare and Optellum today announced that they have signed a letter of intent to collaborate to advance precision diagnosis and treatment of lung cancer. GE Healthcare is a global leader in medical imaging solutions. Optellum is the leader in AI decision support for the early diagnosis and optimal treatment of lung cancer. This press release features multimedia. Together, the companies are seeking to address one of the largest challenges in the diagnosis of lung cancer, helping providers to determine the malignancy of a lung nodule: a suspicious lesion that may be benign or cancerous.

Whether you're planning your annual viewing of White Christmas or gearing up for college football bowl season, now is a great time to upgrade your home theater. This Black Friday has steep discounts on many of our favorite TVs, from massive OLED displays to simple and affordable options with built-in Roku. There are also a wide assortment of great soundbars available for great prices this shopping holiday, making it a perfect time to just upgrade your sound already. Be sure to check out our guides to the Best TVs and Best Soundbars for more information about our favorite models right now. If you buy something using links in our stories, we may earn a commission. This helps support our journalism.

BrainChip Holdings Ltd (ASX: BRN), (OTCQX: BCHPY) a leading provider of ultra-low power high performance artificial intelligence technology and the world's first commercial producer of neuromorphic AI chips and IP, today announced that MegaChips, a pioneer in the ASIC industry, has licensed BrainChip Akida IP to enhance and grow its technology positioning for next-generation, Edge-based AI solutions. A multibillion-dollar global fabless semiconductor company based in Japan, MegaChips provides chip solutions that fulfill various requirements, including low power consumption, cost and time to market, while achieving breakthrough functions and performance by fusing knowledge of Large Scale Integrations and applications for problems in device development. By partnering with BrainChip, MegaChips is able to quickly and easily maintain its industry innovator status by supplying solutions and applications that leverage the Akida revolutionary technology in markets such as automotive, IoT, cameras, gaming and industrial robotics. "As a trusted and loyal partner to market leaders, we deliver the technology and expertise they need to ensure products are uniquely designed for their customers and engineered for ultimate performance," said Tetsuo Hikawa, President and CEO of MegaChips. "Working with BrainChip and incorporating their Akida technology into our ASIC solutions service, we are better able to handle the development and support processes needed to design and manufacture integrated circuits and systems on chips that can take advantage of AI at the Edge."

During (1) the training process, automatic feature extraction from the annotated dataset occurred, while in (2) the prediction step, the obtained residual neural network model classified unlabelled single-particle images. The research is supported by the Russian Science Foundation (grant 21-73-00097). "If one wants to evaluate the effects of microplastics on humans and animals, then among the primary instruments will be a technology to detect microplastics in the organisms or cells. We tried to find out which plastic particles penetrate better into living cells, which ones are more detrimental, where they are localized, and how to distinguish one type of plastic in the body from another," says Dr. Gölnur Fakhrullina, Research Associate of KFU's Bionanotechnology Lab and the principal investigator of this project. The technique used in the publication is based on the imaging the live cells using dark-field microscopy.

The survey also highlights the relative immaturity of AI technologies compared to the other innovation areas. Just over half of respondents report significant target customer adoption of their AI-enabled products and services. Forty-one percent of respondents cited AI emerging technologies as still being in development or early adoption stages, meaning there is a wave of potential adoption as new or augmented AI products and services enter general availability.

SAN ANTONIO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- A new analysis by Verify Markets shows the U.S. pacemaker market was valued over $1.7 billion in 2020 and is expected to witness a steady growth rate during the forecast period. The market is likely to be driven by a growing aging population, rising prevalence of cardiovascular and chronic diseases, and technological advances in pacemaker designs that reduce risk and discomfort. Some examples include the development of leadless pacemakers and MRI-compatible pacemakers. Artificial intelligence techniques have a potential to increase accuracy, reliability, and reduce errors in diagnostic methods, which are likely to help in early diagnosis and implementation of cost-effective treatments for cardiovascular diseases. Pacemakers are increasingly being designed to reduce patient discomfort and are equipped with long lasting batteries and remote accessibility.

SAN FRANCISCO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Rescale, the leading hybrid cloud high performance computing (HPC) platform enabling intelligent computing for digital R&D, today announced it has closed $105 million in an expanded Series C funding round. Existing and new investors in the company include Sam Altman, Jeff Bezos, Richard Branson, Paul Graham, Peter Thiel, Fort Ross Ventures, Gaingels, Gopher, Hitachi Ventures, Initialized Capital, Keen Venture Partners, Microsoft M12, Nautilus Venture Partners, NVIDIA, Prometheus Capital, Republic Labs, Samsung Catalyst Fund, Solasta Ventures, Yield Capital Partners and more. The valuation was not disclosed. Rescale's announcement today follows a dramatic acceleration in customer demand, investor interest and market momentum, bringing the company's total funding to date to over $155 million. With over 200 enterprise customers, and year-over-year sales growing over 2x in 2021, Rescale is accelerating the digital transformation of the computational science and engineering discipline, which has traditionally been on-premises in private data centers but is rapidly shifting to cloud.

The Secret Service has designated Nantucket a "No Drone Zone" ahead of President Biden's Thanksgiving visit. "Due to protective operations in Nantucket, MA, the Secret Service, in coordination with the Federal Aviation Administration (FAA), has established a drone flight restriction from November 23, 2021 to November 28, 2021," the agency said in a press release. The restriction applies to all aircraft and pilots, including drone pilots. The Bidens were scheduled to arrive at Nantucket Memorial Airport at 7:10 p.m. Tuesday, the White House Press Office announced this week. The 46th president is a frequent visitor to the Massachusetts coastal island.

FinancialNewsMedia.com News Commentary - You simply cannot watch television today, without seeing multiple commercials for an eSports betting provider… in fact, it more like you will see multiple ads. It is ubiquitous in this day and age. Esports already feels like a futuristic activity. Pro video gamers now compete against each other for multimillion-dollar prize pools inside of huge arenas. The fact that you can bet on esports only sweetens the pot.

Yet, the reality of AI deployment is much more limited. Gartner research found that organizations commonly experiment with AI but struggle to make the technology a part of their standard operations. Gartner predicts that it will take until 2025 for half of organizations worldwide to reach what Gartner's AI maturity model describes as the "stabilization stage" of AI maturity or beyond.